464 related articles for article (PubMed ID: 28073663)
1. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
2. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y
Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510
[TBL] [Abstract][Full Text] [Related]
3. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
4. A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.
Zhang PH; Gao JL; Pu C; Feng G; Wang LZ; Huang LZ; Zhang Y
Lipids Health Dis; 2016 Aug; 15(1):142. PubMed ID: 27576735
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
[TBL] [Abstract][Full Text] [Related]
6. The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes.
Bekpinar S; Yenidunya G; Gurdol F; Unlucerci Y; Aycan-Ustyol E; Dinccag N
Clin Biochem; 2015 Dec; 48(18):1264-7. PubMed ID: 26255120
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
8. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
9. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
10. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
12. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.
Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B
Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779
[TBL] [Abstract][Full Text] [Related]
14. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
16. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease.
Ay L; Hoellerl F; Ay C; Brix JM; Koder S; Schernthaner GH; Pabinger I; Schernthaner G
Eur J Clin Invest; 2012 May; 42(5):470-7. PubMed ID: 21955218
[TBL] [Abstract][Full Text] [Related]
17. The association between apolipoprotein M and insulin resistance varies with country of birth.
Memon AA; Bennet L; Zöller B; Wang X; Palmér K; Dahlbäck B; Sundquist J; Sundquist K
Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1174-80. PubMed ID: 24984825
[TBL] [Abstract][Full Text] [Related]
18. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
